Aspiriant LLC’s Zscaler ZS Stock Holding History

Aspiriant LLC’s Portfolio ZS Stock Details ZS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-694	Closed	-$218K	–	322
2025 Q2	$218K	Buy	+694	New	+$173K	0.01%	297

Other funds holding ZS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aspiriant LLC's ZS Position: Q3 2025 in Review

Aspiriant LLC sold out of Zscaler (ZS) in Q3 2025, closing a stake of 694 shares — an estimated $218K sold.

Aspiriant LLC first reported a position in ZS in Q2 2025 and held it in 1 quarter. The position peaked at $218K in Q2 2025. 910 funds tracked by Wall St. Rank hold ZS as of Q3 2025.

Aspiriant LLC reported no remaining Zscaler position as of Q3 2025 after selling out during the quarter.
Aspiriant LLC sold 694 Zscaler shares in Q3 2025, an estimated $218K.
Aspiriant LLC first reported a position in Zscaler in Q2 2025 and held it in 1 quarter.
Aspiriant LLC's Zscaler position peaked at $218K in Q2 2025.
910 funds tracked by Wall St. Rank held Zscaler as of Q3 2025.

Based on Aspiriant LLC's 13F filing for Q3 2025, filed 24 Oct 2025.